 azt activ cell line implic combin chemotherapi immunotherapi sensit quantit focal immunoassay effect differ therapeut agent tissu cultur cell human immunodefici viru hiv effect drug cell line agent azidothymidin azt interferon-alpha ifn-alpha anti-hiv envelop antibodi chain combin azt effect earli stage infect action cell line effect azt cell extend exposur drug remov ifn-alpha variabl effect infect cell chronic infect combin therapeut agent model treatment acut persist stage infect effect combin hiv infect continu use azt ifn-alpha toler dose knowledg efficaci azt cell effect design clinic protocol